Your session is about to expire
← Back to Search
D2S Intervention for HIV (D2S Trial)
N/A
Waitlist Available
Led By Denis Nash, PhD
Research Sponsored by City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Summary
This trial will help researchers understand how to better help low-income people with HIV achieve viral suppression, which is key to reducing HIV health disparities and scaling up evidence-based interventions.
Who is the study for?
This trial is for low-income individuals in New York City with HIV who are already receiving care but have not achieved viral suppression. They must have had at least one viral load test showing unsuppressed levels and be enrolled in eligible Ryan White HIV/AIDS Program services.
What is being tested?
The study tests a 'data-to-suppression' (D2S) strategy aimed at improving viral suppression among patients using behavioral health and housing support programs within the Ryan White HIV/AIDS Program, by providing targeted interventions based on surveillance data.
What are the potential side effects?
Since this intervention involves data management and personalized support rather than medication, traditional side effects associated with drugs are not applicable. However, there may be privacy concerns or stress related to increased monitoring.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Timely viral suppression
Secondary study objectives
Time to viral suppression
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Early ImplementationExperimental Treatment1 Intervention
This arm will receive D2S intervention components during Period 1 (Early Implementation) as well as throughout Period 2 of the stepped-wedge trial.
Group II: Delayed ImplementationActive Control1 Intervention
This arm will receive no D2S intervention components during Period 1 (Early Implementation), but will then receive all D2S intervention components in Period 2, starting 12 months later.
Find a Location
Who is running the clinical trial?
New York City Department of Health and Mental HygieneOTHER_GOV
18 Previous Clinical Trials
17,046 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,869 Previous Clinical Trials
2,775,917 Total Patients Enrolled
City University of New YorkLead Sponsor
17 Previous Clinical Trials
4,157 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Early Implementation
- Group 2: Delayed Implementation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger